Serotonin transporter genotype and function in relation to antidepressant response in Koreans

Psychopharmacology

Volumn 225, Issue 2, 2013, Pages 283-290

  Myung, Woojae ^a   Lim, Shinn Won ^b   Kim, Seonwoo ^b   Kim, Hyeran ^a   Chung, Jae Won ^a   Seo, Min Young ^a   Kim, Jong Won ^a   Carroll, Bernard J ^c   Kim, Doh Kwan ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Pacific Behavioral Research Foundation   (United States)

Author keywords

Antidepressant response; Ethnic variation; Gene expression; Serotonin transporter; Transporter function

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; SEROTONIN TRANSPORTER; SERTRALINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG RESPONSE; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENETIC POLYMORPHISM; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SEROTONIN TRANSPORTER GENE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PLATELETS; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; FLUOXETINE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; REPUBLIC OF KOREA; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TREATMENT OUTCOME;

EID: 84872291237     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2813-y     Document Type: Article

References (40)

1. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR, 4th edn. American Psychiatric Association, Washington, DC
2. Anderson IM (2000) Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 58:19-36
3. Colligan RC, Osborne D, Swenson WM, Offord KP (1984) The MMPI: development of contemporary norms. J Clin Psychol 40:100-107
4. Da Prada M, Cesura AM, Launay JM, Richards JG (1988) Platelets as a model for neurones? Experientia 44:115-126
5. Franke L, Schewe HJ, Uebelhack R, Muller-Oerlinghausen B (2003) High platelet-serotonin uptake activity is associated with a rapid response in depressed patients treated with amitriptyline. Neurosci Lett 345:105-108
6. Fredman SJ, Fava M, Kienke AS, White CN, Nierenberg AA, Rosenbaum JF (2000) Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: a survey of current "next-step" practices. J Clin Psychiatry 61:403-408
7. Gelernter J, Kranzler H, Cubells JF (1997) Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects. Hum Genet 101:243-246
8. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL (1999) Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 88:83-87
9. Hachisu M, Ichimaru Y (2000) Pharmacological and clinical aspects of fluvoxamine (Depromel), the first selective serotonin reuptake inhibitor approved for clinical use employed in Japan. Nippon Yakurigaku Zasshi 115:271-279
10. Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278-296
11. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621-2624
12. Heils A, Mossner R, Lesch KP (1997) The human serotonin transporter gene polymorphism - basic research and clinical implications. J Neural Transm 104:1005-1014
13. Hranilovic D, Stefulj J, Schwab S, Borrmann-Hassenbach M, Albus M, Jernej B, Wildenauer D (2004) Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression. Biol Psychiatry 55:1090-1094. doi: 10.1016/j.biopsych.2004.01.029
14. Kim DK, Lim SW, Lee S, Sohn SE, Kim S, Hahn CG, Carroll BJ (2000) Serotonin transporter gene polymorphism and antidepressant response. Neuroreport 11:215-219
15. Kim H, Lim SW, Kim S, Kim JW, Chang YH, Carroll BJ, Kim DK (2006) Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression. JAMA 296:1609-1618. doi: 10.1001/jama.296.13.1609
16. Kiyohara C, Yoshimasu K (2009) Molecular epidemiology of major depressive disorder. Environ Health Prev Med 14:71-87. doi: 10.1007/s12199-008-0073-6
17. Kugaya A, Sanacora G, Staley JK, Malison RT, Bozkurt A, Khan S, Anand A, Van Dyck CH, Baldwin RM, Seibyl JP, Charney D, Innis RB (2004) Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors. Biol Psychiatry 56:497-502. doi: 10.1016/j.biopsych.2004. 07.001
18. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531
19. Mellerup E, Bennike B, Bolwig T, Dam H, Hasholt L, Jorgensen MB, Plenge P, Sorensen SA (2001) Platelet serotonin transporters and the transporter gene in control subjects, unipolar patients and bipolar patients. Acta Psychiatr Scand 103:229-233
20. Meltzer HY, Arora RC, Baber R, Tricou BJ (1981) Serotonin uptake in blood platelets of psychiatric patients. Arch Gen Psychiatry 38:1322-1326
21. Nobile M, Begni B, Giorda R, Frigerio A, Marino C, Molteni M, Ferrarese C, Battaglia M (1999) Effects of serotonin transporter promoter genotype on platelet serotonin transporter functionality in depressed children and adolescents. J Am Acad Child Adolesc Psychiatry 38:1396-1402. doi: 10.1097/00004583-199911000-00014
22. O'Reilly RL, Bogue L, Singh SM (1994) Pharmacogenetic response to antidepressants in a multicase family with affective disorder. Biol Psychiatry 36:467-471
23. Orsulak PJ, Liu PK, Akers LC (2001) Antidepressant drugs. In: Shaw LM (ed) Clinical toxicology laboratory: contemporary practice of poisoning evaluation. AACC Press, Washington, DC, pp 223-236
24. Owens MJ, Nemeroff CB (1994) Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 40:288-295
25. Peterson NA, Raghupathy E (1973) Developmental transitions in uptake of amino acids by synaptosomal fractions isolated from rat cerebral cortex. J Neurochem 21:97-110
26. Pollock BG, Ferrell RE, Mulsant BH, Mazumdar S, Miller M, Sweet RA, Davis S, Kirshner MA, Houck PR, Stack JA, Reynolds CF, Kupfer DJ (2000) Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology 23:587-590. doi: 10.1016/S0893-133X(00)00132-9
27. Porcelli S, Fabbri C, Serretti A (2012) Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy. Eur Neuropsychopharmacol 4:239-258
28. Ramamoorthy S, Giovanetti E, Qian Y, Blakely RD (1998) Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J Biol Chem 273:2458-2466
29. Rausch JL (2005) Initial conditions of psychotropic drug response: studies of serotonin transporter long promoter region (5-HTTLPR), serotonin transporter efficiency, cytokine and kinase gene expression relevant to depression and antidepressant outcome. Prog Neuropsychopharmacol Biol Psychiatry 29:1046-1061. doi: 10.1016/j.pnpbp.2005.03.011
30. Rausch JL, Johnson ME, Fei YJ, Li JQ, Shendarkar N, Hobby HM, Ganapathy V, Leibach FH (2002) Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome. Biol Psychiatry 51:723-732
31. Shaw DM, MacSweeney DA, Woolcock N, Bevan-Jones AB (1971) Uptake and release of 14 C-5-hydroxytryptamine by platelets in affective illness. J Neurol Neurosurg Psychiatry 34:224-225
32. Slotkin TA, McCook EC, Ritchie JC, Seidler FJ (1996) Do glucocorticoids contribute to the abnormalities in serotonin transporter expression and function seen in depression? An animal model. Biol Psychiatry 40:576-584
33. Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M (1998) Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 3:508-511
34. Taylor MJ, Sen S, Bhagwagar Z (2010) Antidepressant response and the serotonin transporter gene-linked polymorphic region. Biol Psychiatry 68:536-543
35. Tournel G, Houdret N, Hedouin V, Deveau M, Gosset D, Lhermitte M (2001) High-performance liquid chromatographic method to screen and quantitate seven selective serotonin reuptake inhibitors in human serum. J Chromatogr B Biomed Sci Appl 761:147-158
36. Walsh BT, Seidman SN, Sysko R, Gould M (2002) Placebo response in studies of major depression: variable, substantial, and growing. JAMA 287:1840-1847
37. Wirz-Justice A, Puhringer W (1978) Seasonal incidence of an altered diurnal rhythm of platelet serotonin in unipolar depression. J Neural Transm 42:45-53
38. Yoshida K, Ito K, Sato K, Takahashi H, Kamata M, Higuchi H, Shimizu T, Itoh K, Inoue K, Tezuka T, Suzuki T, Ohkubo T, Sugawara K, Otani K (2002) Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 26:383-386
39. Yu YW, Tsai SJ, Chen TJ, Lin CH, Hong CJ (2002) Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol Psychiatry 7:1115-1119. doi: 10.1038/sj.mp.4001141
40. Zivin JA, Waud DR (1982) How to analyze binding, enzyme and uptake data: the simplest case, a single phase. Life Sci 30:1407-1422